Migratory Leukocytes in the Pathogenesis and Diagnosis of Prion Disease

Abstract

Of all infectious diseases, prions remain the least understood and most difficult to study. Although it is generally accepted that immune cells are key components to the pathogenesis of the disease, relatively little is understood regarding their involvement. It is the goal of this work to understand the role(s) of migratory immune cells, including B cells and dendritic cells, in the pathogenesis of transmissible spongiform encepthalopathies. To this end, we have two specific tasks: to understand the expression of the normal prion protein on immune cells in sheep, and to use that knowledge to investigate the potential role of migratory B cells in TSEs. Here, we describe our work which clearly demonstrated differences in the expression of PrP on the surface of B cells and B cell subsets, linked to the genetic background of the animal (i.e. scrapie susceptibility). In addition experiments on scrapie infected animals, we found that these same subsets appeared to be disrupted in infected as compared to normal animals, suggesting a potential effect of scrapie on the differentiation of B cells in lymph node germinal centers. This work has direct relevance to both the understanding and potential diagnosis of prion diseases in sheep and other species.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2004
Accession Number
ADA426355

Entities

People

  • Alan J. Young

Organizations

  • South Dakota State University

Tags

DTIC Thesaurus Topics

  • Antibodies
  • Antigens
  • Blood
  • Cell Line
  • Cells
  • Diseases And Disorders
  • Histological Techniques
  • Immune System
  • Infection
  • Leukocytes
  • Lymph Nodes
  • Lymphatic System
  • Lymphocytes
  • Pathogenesis
  • Proteins
  • South Dakota
  • Surgery

Fields of Study

  • Biology

Readers

  • Criminal Law
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Immunology

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech